CytomX Therapeutics Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - CytomX Therapeutics (NASDAQ:CTMX)
By Avi Kapoor
Published on March 16, 2026.
CytomX Therapeutics, Inc. will release its fourth-quarter earnings on March 16, with analysts expecting a loss of 9 cents per share, compared to the year's profit of 23 cents. The consensus estimate for the company's quarterly revenue is $7.33 million. Shares of the company fell 3.9% to close at $4.68 on Friday.
Related Articles
Nasdaq Falls Over 200 Points Amid GDP Revision: Investor Sentiment Declines, Fear & Greed Index In 'Extreme Fear' Zone - Semtech (NASDAQ:SMTC)
US stocks fell over 200 points as investors weighed a weaker GDP estimate and increased fear, despite a slight rise in the Fear & Greed Index.
India Wholesale Price Index (WPI) Inflation (YoY) For February 2.13% Vs. 2.00% Est.; 1.81% Prior - iShares MSCI India ETF (BATS:INDA)
The following article by Steve N. Smith's staff:.
Reported Friday, Thomson Reuters Files Documents For Proposed $605M Special Cash Distribution And Reverse Stock Split Subject To Shareholder Approval On April 28 - Thomson Reuters (NASDAQ:TRI)
Despite the controversy over a potential $6.5m payout, Thomson Reuters has filed for approval for a proposed $6m payout;.